Study of translational clinical application of chimeric antigen receptor T cells in the treatment of relapse / refractory hematologic malignancies

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2020
This article has no abstract
Epistemonikos ID: 6716d398188f3d001d4262196b5bec9464b456e1
First added on: Apr 07, 2025